Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A patient's perspective on hemophilia.

Ellis Sulser1

  • 1Factor Support Network Pharmacy, Inc, Camarillo, CA 39012-8749, USA. ellissulser@factorsupport.com

Seminars in Hematology
|April 25, 2006
PubMed
Summary

Patients with hemophilia and their doctors must collaborate to ensure the safest, most effective treatments. Informed choices require evaluating therapy safety, purity, cost, and convenience for optimal health outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Pain in SCD-Many mechanisms and mysteries.

Seminars in hematology·2026
Same journal

The many facets of cardiopulmonary complications in sickle cell disease.

Seminars in hematology·2026
Same journal

Clonal hematopoiesis in the setting of sickle cell disease and its relevance to curative therapies.

Seminars in hematology·2026
Same journal

Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.

Seminars in hematology·2026
Same journal

Telomeres biology disorders: the past, the present and the future.

Seminars in hematology·2026
Same journal

Cardiovascular complications in patients with myeloproliferative neoplasms: What hematologists need to know.

Seminars in hematology·2026

Area of Science:

  • Hematology
  • Patient Care
  • Public Health

Background:

  • Hemophilia management requires active patient-physician partnership for optimal outcomes.
  • Therapy selection involves assessing safety, purity, cost, and convenience, with safety as the primary concern.
  • Historical challenges, including the acquired immune deficiency syndrome (AIDS) epidemic, underscore the need for vigilant safety monitoring.

Purpose of the Study:

  • To emphasize the critical role of informed patient choice in hemophilia therapy selection.
  • To highlight the responsibilities of healthcare providers in guiding patients toward optimal treatment decisions.
  • To advocate for standards of care that prioritize patient safety and quality of life.

Main Methods:

  • This abstract is a review and discussion of current hemophilia management principles.
  • It synthesizes information on patient-physician collaboration, informed consent, and therapy assessment criteria.
  • It considers ethical, psychosocial, and quality-of-life factors in hemophilia care.

Main Results:

  • Informed patients, in partnership with healthcare providers, can achieve better clinical and economic outcomes.
  • Access to comprehensive information is crucial for patients to make sound therapy choices.
  • Continuous re-evaluation of disease management by healthcare providers is essential for optimizing patient outcomes.

Conclusions:

  • Patient safety must remain the paramount consideration in hemophilia therapy.
  • Healthcare policies must integrate medical ethics, psychosocial support, and quality-of-life considerations.
  • Ensuring access to the safest therapies allows individuals with hemophilia to lead lives with minimal disruption.

Related Experiment Videos